Originalkatalog | Verfügbarkeit prüfen

PCN190 - COST-EFFECTIVENESS OF NIVOLUMAB + IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC RENAL CELL CARCINOMA IN THE NETHERLANDS

Klijn, S., Van de Wetering, G., Malcolm, B., Dale, P., Pompen, M., Stevanovic, J.
Veröffentlicht in: Value in Health ; volume 21, page S46 ; ISSN 1098-3015;
2018

Originalkatalog | Verfügbarkeit prüfen

EE309 Cost-Effectiveness of Mavacamten for the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy in the Netherlands

Buisman, L., Treur, M., Verkaik, M., Van De Wetering, G., Pronk, L.M., Pompen, M., Hurst, M.
Veröffentlicht in: Value in Health ; volume 26, issue 12, page S110 ; ISSN 1098-3015;
2023

Originalkatalog | Verfügbarkeit prüfen

Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE

Klijn, S.L., van den Reek, J.M.P.A., van de Wetering, G., van der Kolk, A., de Jong, E.M.G.J., Kievit, W.
Veröffentlicht in: British Journal of Dermatology ; volume 178, issue 5, page 1181-1189 ; ISSN 0007-0963;
2018

Originalkatalog | Verfügbarkeit prüfen

Cost-Effectiveness of Ticagrelor 60 Mg in High-Risk Post-Mi Patients From A Dutch Societal Perspective

Moore, P, Briggs, A, Davies, A, Sculpher, M, Williams, J, Fenwick, E, van de Wetering, G, Magnuson, EA, Cohen, DJ, van Haalen, HG, Mellstrom, C
Veröffentlicht in: Value in Health ; volume 19, issue 7, page A654-A655 ; ISSN 1098-3015;
2016